⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor

Official Title: Phase III Randomized, Intergroup Trial Assessing the Clinical Activity Of STI-571 at Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors (GIST) Expressing the Kit Receptor Tyrosine Kinase (CD117)

Study ID: NCT00009906

Interventions

Imatinib Mesylate

Study Description

Brief Summary: Randomized phase III trial to compare the effectiveness of two different doses of STI571 in treating patients who have metastatic or unresectable gastrointestinal stromal tumor. STI571 may interfere with the growth of tumor cells and may be an effective treatment for cancer. It is not yet known which dose of STI571 is more effective in treating gastrointestinal stromal tumors.

Detailed Description: PRIMARY OBJECTIVES: I. Compare the overall and progression-free survival of patients with CD117-expressing metastatic or unresectable gastrointestinal stromal tumor treated with two different doses of imatinib mesylate. II. Compare the confirmed, unconfirmed, complete, and partial response rates in patients treated with these regimens. III. Compare the toxic effects of these regimens in these patients. OUTLINE: This is a randomized study. Patients are randomized to one of two treatment arms. Arm I: Patients receive oral imatinib mesylate once daily. Arm II: Patients receive oral imatinib mesylate twice daily. Treatment continues in the absence of disease progression or unacceptable toxicity. Patients in arm I with progressive disease may cross over to arm II and receive treatment in the absence of further disease progression. Patients are followed every 3 months for 1 year, every 6 months for 2 years, and then annually thereafter. PROJECTED ACCRUAL: A total of 600 patients will be accrued for this study within 24 months.

Keywords

Eligibility

Minimum Age: 15 Years

Eligible Ages: CHILD, ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Western Regional CCOP, Phoenix, Arizona, United States

University of Arizona Health Sciences Center, Tucson, Arizona, United States

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

Highlands Oncology Group-Rogers, Rogers, Arkansas, United States

City of Hope Comprehensive Cancer Center, Duarte, California, United States

Long Beach Community Hospital, Long Beach, California, United States

University of Southern California/Norris Cancer Center, Los Angeles, California, United States

University of California at Los Angeles Health System, Los Angeles, California, United States

Sutter Cancer Research Consortium, Novato, California, United States

University of California Davis Comprehensive Cancer Center, Sacramento, California, United States

Kaiser Permanente - Sacramento, Sacramento, California, United States

University of California San Diego, San Diego, California, United States

UCSF Medical Center-Mount Zion, San Francisco, California, United States

Santa Rosa Memorial Hospital, Sana Rosa, California, United States

Stanford University Hospitals and Clinics, Stanford, California, United States

Presbyterian - Saint Lukes Medical Center - Health One, Denver, Colorado, United States

Rose Medical Center, Denver, Colorado, United States

Swedish Medical Center, Englewood, Colorado, United States

Poudre Valley Hospital, Fort Collins, Colorado, United States

Saint Mary Corwin Medical Center, Pueblo, Colorado, United States

Middlesex Hospital, Middletown, Connecticut, United States

MedStar Oncology Network, Washington, District of Columbia, United States

Mayo Clinic in Florida, Jacksonville, Florida, United States

Hematology Oncology Associates, Lake Worth, Florida, United States

Florida Hospital Orlando, Orlando, Florida, United States

Moffitt Cancer Center, Tampa, Florida, United States

Phoebe Putney Memorial Hospital, Albany, Georgia, United States

Emory University/Winship Cancer Institute, Atlanta, Georgia, United States

Atlanta Regional CCOP, Atlanta, Georgia, United States

Medical Center of Central Georgia, Macon, Georgia, United States

University of Hawaii Cancer Center, Honolulu, Hawaii, United States

Hematology and Oncology Associates, Chicago, Illinois, United States

Northwestern University, Chicago, Illinois, United States

Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois, United States

Rush University Medical Center, Chicago, Illinois, United States

University of Illinois, Chicago, Illinois, United States

University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

Central Illinois CCOP, Decatur, Illinois, United States

Alexian Brothers Medical and Cancer Center, Elk Grove Village, Illinois, United States

NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois, United States

Loyola University Medical Center, Maywood, Illinois, United States

Mid-Illinois Hematology Oncology Associates, Normal, Illinois, United States

Advocate Lutheran General Hospital., Park Ridge, Illinois, United States

Carle Cancer Center, Urbana, Illinois, United States

Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States

IU Health Methodist Hospital, Indianapolis, Indiana, United States

McFarland Clinic PC-William R Bliss Cancer Center, Ames, Iowa, United States

University of Kansas Medical Center, Kansas City, Kansas, United States

Kansas City CCOP, Prairie Village, Kansas, United States

Stormont-Vail Regional Health Center, Topeka, Kansas, United States

Our Lady Bellefonte Hospital, Ashland, Kentucky, United States

Louisiana State University Health Science Center, New Orleans, Louisiana, United States

Sinai Hospital of Baltimore, Baltimore, Maryland, United States

Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States

Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Michigan Cancer Research Consortium Community Clinical Oncology Program, Ann Arbor, Michigan, United States

University of Michigan University Hospital, Ann Arbor, Michigan, United States

Oakwood Hospital and Medical Center, Dearborn, Michigan, United States

Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States

Henry Ford Hospital, Detroit, Michigan, United States

Grand Rapids Clinical Oncology Program, Grand Rapids, Michigan, United States

West Michigan Cancer Center, Kalamazoo, Michigan, United States

Marquette General Hospital, Marquette, Michigan, United States

Unity Hospital, Fridley, Minnesota, United States

University of Minnesota Medical Center-Fairview, Minneapolis, Minnesota, United States

North Memorial Medical Health Center, Robbinsdale, Minnesota, United States

Mayo Clinic, Rochester, Minnesota, United States

Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States

Regions Hospital, Saint Paul, Minnesota, United States

University of Mississippi Medical Center, Jackson, Mississippi, United States

Saint Joseph's Health Center, Saint Charles, Missouri, United States

Saint Louis Cancer and Breast Institute-South City, Saint Louis, Missouri, United States

Barnes-Jewish Hospital, Saint Louis, Missouri, United States

Missouri Baptist Medical Center, Saint Louis, Missouri, United States

Ozark Health Ventures LLC-Cancer Research for The Ozarks Springfield, Springfield, Missouri, United States

Alegent Health Immanuel Medical Center, Omaha, Nebraska, United States

Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States

Hackensack University Medical CCOP, Hackensack, New Jersey, United States

Saint Barnabas Medical Center, Livingston, New Jersey, United States

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

University of New Mexico, Albuquerque, New Mexico, United States

Albert Einstein College of Medicine, Bronx, New York, United States

Montefiore Medical Center - Moses Campus, Bronx, New York, United States

Roswell Park Cancer Institute, Buffalo, New York, United States

Winthrop University Hospital, Mineola, New York, United States

Beth Israel Medical Center, New York, New York, United States

New York University Langone Medical Center, New York, New York, United States

Columbia University Medical Center, New York, New York, United States

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

University of North Carolina, Chapel Hill, North Carolina, United States

Duke University Medical Center, Durham, North Carolina, United States

Southeast Cancer Control Consortium CCOP, Winston-Salem, North Carolina, United States

Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Roger Maris Cancer Center, Fargo, North Dakota, United States

Case Western Reserve University, Cleveland, Ohio, United States

Cleveland Clinic Foundation, Cleveland, Ohio, United States

Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Columbus CCOP, Columbus, Ohio, United States

Dayton CCOP, Dayton, Ohio, United States

Saint Rita's Medical Center, Lima, Ohio, United States

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

Sky Lakes Medical Center - Cancer Treatment Center, Klamath Falls, Oregon, United States

Western Oncology Research Consortium, Portland, Oregon, United States

Oregon Health and Science University, Portland, Oregon, United States

Salem Hospital, Salem, Oregon, United States

Geisinger Medical Center, Danville, Pennsylvania, United States

Mercy Fitzgerald Hospital, Darby, Pennsylvania, United States

Delaware County Memorial Hospital, Drexel Hill, Pennsylvania, United States

University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States

Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

Aria Health-Torresdale Campus, Philadelphia, Pennsylvania, United States

Albert Einstein Medical Center, Philadelphia, Pennsylvania, United States

Rhode Island Hospital, Providence, Rhode Island, United States

Upstate Carolina CCOP, Spartanburg, South Carolina, United States

Baptist Memorial Hospital and Cancer Center-Memphis, Memphis, Tennessee, United States

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

M D Anderson Cancer Center, Houston, Texas, United States

Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States

Central Vermont Medical Center, Barre, Vermont, United States

Central Vermont Medical Center/National Life Cancer Treatment, Berlin, Vermont, United States

Rutland Regional Medical Center, Rutland, Vermont, United States

Virginia Oncology Associates-Hampton, Hampton, Virginia, United States

Virginia Mason CCOP, Seattle, Washington, United States

Group Health, Seattle, Washington, United States

Cancer Care Northwest - Spokane South, Spokane, Washington, United States

Northwest CCOP, Tacoma, Washington, United States

Saint Vincent Hospital, Green Bay, Wisconsin, United States

University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States

Marshfield Clinic, Marshfield, Wisconsin, United States

Tom Baker Cancer Centre, Calgary, Alberta, Canada

Cross Cancer Institute, Edmonton, Alberta, Canada

BCCA-Vancouver Cancer Centre, Vancouver, British Columbia, Canada

Hamilton and District Urology Association McMaster Institute, Hamilton, Ontario, Canada

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada

London Regional Cancer Program, London, Ontario, Canada

Ottawa Health Research Institute-General Division, Ottawa, Ontario, Canada

Mount Sinai Hospital, Toronto, Ontario, Canada

CHUM - Hopital Notre-Dame, Montreal, Quebec, Canada

McGill University Department of Oncology, Montreal, Quebec, Canada

San Juan Veterans Affairs Medical Center, San Juan, , Puerto Rico

San Juan City Hospital, San Juan, , Puerto Rico

Contact Details

Name: George Demetri

Affiliation: SWOG Cancer Research Network

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: